One68 Global Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

One68 Global Capital’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-197,329	Closed	-$26M	–	89
2025 Q1	$26M	Buy	+197,329	New	+$24.6M	12.78%	1

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

One68 Global Capital's ITCI Position: Q2 2025 in Review

One68 Global Capital sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 197,329 shares — an estimated $26M sold.

One68 Global Capital first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $26M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

One68 Global Capital reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
One68 Global Capital sold 197,329 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $26M.
One68 Global Capital first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
One68 Global Capital's Intra-Cellular Therapies Inc. position peaked at $26M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on One68 Global Capital's 13F filing for Q2 2025.